Accurate assessment of mitral regurgitation (MR) severity is important for clinical decision making, prognostication, and decisions regarding timing of surgical intervention. The most common method for noninvasive assessment of MR has been with 2-dimensional transthoracic echocardiography, which is often used as a qualitative tool. Several newer noninvasive modalities including 3-dimensional echocardiography, cardiac magnetic resonance imaging, and cardiac computed tomography have also become available for this purpose; however, their role in routine clinical practice is not clearly defined. In this review, we provide an overview of these newer modalities for quantitative assessment of MR severity. Mitral regurgitation (MR) remains one of the most common valvular heart diseases (1). Patients with moderate to severe MR have a high likelihood of developing symptoms of left ventricular (LV) dysfunction, and the 5-year cardiovascular disease-related mortality rate in selected, untreated asymptomatic patients is up to 14% (2,3). Substantial progress in the surgical treatment of MR has improved life expectancy (3,4), but prognosis and decisions regarding timing of surgery depend on the accurate quantification of MR severity (3,5). Advances in 3-dimensional echocardiography (3DE), cardiac magnetic resonance (CMR) imaging, and cardiac computed tomography (CCT) have provided new tools for MR quantification (Table 1) .
Mitral regurgitation (MR) remains one of the most common valvular heart diseases (1). Patients with moderate to severe MR have a high likelihood of developing symptoms of left ventricular (LV) dysfunction, and the 5-year cardiovascular disease-related mortality rate in selected, untreated asymptomatic patients is up to 14% (2, 3) . Substantial progress in the surgical treatment of MR has improved life expectancy (3, 4) , but prognosis and decisions regarding timing of surgery depend on the accurate quantification of MR severity (3, 5) . Advances in 3-dimensional echocardiography (3DE), cardiac magnetic resonance (CMR) imaging, and cardiac computed tomography (CCT) have provided new tools for MR quantification (Table 1) .
This review of MR quantification methods using newer imaging modalities focuses on the diagnostic and prognostic value and reproducibility of each technique by a systematic review of the existing literature, and the benefits and limitations of the various techniques. When available, the performance characteristics of the 2-dimensional echocardiographic (2DE) techniques are also described. With respect to 3DE, our review focuses on studies that have used contemporary realtime imaging rather than reconstructive 3DE techniques.
Literature Review
A MEDLINE (1980 to January 2012) search was performed by 2 of the authors independently, using the search terms mitral regurgitation, quantification, 3D-echocardiography, cardiac magnetic resonance imaging, cardiac computed tomography, and their variations as key words on the OVID search engine. The search was limited to studies in humans and published in the English language. All citations were screened for inclusion by using a hierarchical approach of assessing the title, abstract, and manuscript. Studies that used reconstructive 3DE, did not provide separate data for patients with MR, enrolled only pediatric patients, did not have a reference standard, or were reviews were excluded. References of all selected articles and relevant reviews were screened to identify additional studies.
Vena Contracta Area
Validation of VCA measurements by 3DE. Grading of MR severity using vena contracta is based on estimating the effective regurgitant orifice area (EROA). With 2DE this is mainly limited to a vena contracta width (VCW) measurement from a transthoracic parasternal long-axis or a longaxis transesophageal echocardiographic (TEE) view (6) . Alternatively a vena contracta area (VCA) can be calculated using a shape assumption (7, 8) or by obtaining a short-axis en face view of the MR jet for planimetry (9) . However, 3DE (transthoracic and transesophageal) affords the ability to measure the VCA using 3D-color Doppler acquisition of the MR jet followed by multiplanar reformatting to obtain an en face view of the VCA (Fig. 1) . Studies comparing this technique to various reference standards (Table 2) have uniformly demonstrated it to be more accurate than 2D VCW measurement of MR severity. A cutoff of 0.41 cm 2 using 3D-VCA to differentiate moderate from severe MR showed an 82% sensitivity and 97% specificity (10) . Because this technique is relatively new, its test-retest characteristics, prognostic value, threshold for severity classifications, and multicenter studies of accuracy and reproducibility remain undefined. Benefits and limitations of 3D VCA measurements. Most studies assessing MR severity using 3DE are based on VCA measurements ( Table 2 ). The most important benefit of this method is that the EROA is measured without any flow or geometric assumptions. This is especially important in functional MR (in which MR occurs along the length of the valve coaptation), and in other cases in which the regurgitant orifice is noncircular (7, 8, 11) . 3D-VCA measurements appear accurate even in asymmetric regurgitant orifices, unaffected by the etiology or eccentricity of MR (8,10 -14) , although 2DE was used as reference standards in all but 4 studies (8, 12, 15, 16) . The 3D-VCA technique may reclassify patients into more accurate MR severity classes when compared to 2D-EROA or VCW (10, 12, 13) .
The 3D-VCA technique has several limitations. The limited spatial resolution of the reconstructed image poses a particular problem with small regurgitant orifice area (10, 14) but may not be as important in moderate to severe MR. A comparison of the apical to parasternal acquisition where the measurement of the VCA would be made in the axial plane has not shown significant difference in accuracy (14) . Second, the choice of the systolic frame affects VCA measurement, depending on MR etiology (17, 18) , resulting in interobserver variability (Fig. 1, Panel A2) . A third limitation is that 3D-VCA is easily affected by the multiplanar reformatting process used to obtain the cross-sectional plane for planimetry. This is particularly challenging when the regurgitant jet is highly eccentric, as cropping the regurgitant jet in a nonorthogonal manner can overestimate VCA. Although 1 study suggests that the VCA may be preserved over a distance of 5 to 10 mm distal to the orifice (19) , in our experience, small variations in this location of the VCA measurement ( Fig. 1 , blue plane) can significantly change the area (Fig. 1, Panel B2 ). In addition, the measurement can be affected by color bleeding into the grayscale image, resulting in overestimation of VCA. Therefore, calibration of results from various cropping planes with other severity data is necessary in each laboratory before this technique can be clinically applicable. Fourth, while this method is less time-consuming than other techniques, the post-processing still requires a significant time commitment (up to 2 minutes in experienced hands) and expertise. Whether this will prove clinically practical in a busy echocardiography laboratory remains to be determined. Finally, the use of stitched 3D volumes predisposes to stitching artifact, which will affect the accuracy of the measurements. Although using nonstitched 3D acquisitions may help to overcome this problem, this technique is still often limited by temporal and spatial resolution. Validation, benefits, and pitfalls of VCA measurements by CMR and CCT. With CMR cine-imaging, highvelocity flow across the regurgitant orifice causes a flow void due to dephasing of protons (Fig. 2 ) that can be potentially used for VCW ( Figs. 2A and 2B ) or VCA measurements. This flow void is typically better seen with fast gradient recalled echo (GRE) (Fig. 2B ) cines with longer echo times (20) than the more commonly used steadystate free precession ( Fig. 2A) cines that have lower sensitivity to flow due to short repetition time and echo times. Although not formally referred to as VCA, the regurgitant flow area at the mitral valve has been shown to be measurable with short-axis GRE cines using the flow void (21) or with through-plane phase contrast (PC) imaging (Figs. 2C to 2D) (22) . In the first study, the measured area clearly differentiated MR severity categories when compared to echocardiography or ventriculography (21) , whereas in the second study, good correlation (r ϭ 0.82) was seen with EROA by echocardiography, with areas of 0.27 and 0.92 cm 2 differentiating mild from moderate and moderate from severe MR, respectively (22) . Despite these data, the VCA technique is not commonly used clinically due to limitations such as through-plane motion of the slice position and partial volume effects making the measurement challenging. However, long-axis cines or short-axis PC imaging can be useful for the visual determination of the presence of MR and semiquantitative assessment of severity (20, 23, 24) .
Valvular flow assessment is currently not possible with CCT imaging.
MR Volume and MR Fraction Measurements
Validation of MR volume and MR Fraction techniques by 3DE. Quantification of MR volume (RVol) and fraction (RF) using 3DE can be performed in several ways. The 3D-VCA (discussed earlier) or 3D proximal isovelocity surface area (PISA) based EROA or anatomic regurgitant orifice area (AROA; both discussed subsequently) coupled with the MR velocity time integral from continuous wave Doppler can be A more novel method is to use 3D color Doppler to measure mitral inflow and LV outflow tract (LVOT) SV and to use the difference to obtain RVol (25) . RF can be calculated as (RVol/Mitral inflow SV) ϫ 100. This technique uses the velocity assignment intrinsic to color Doppler combined with the mitral annular and LVOT area (based on the space occupied by the color Doppler) to calculate SV at each orifice ( Fig. 3) (25) . This can be more accurate and reproducible than 2D pulsed-wave Doppler-based methods (25, 26) . Table 3 3D ϭ 3-dimensional; 3DE ϭ 3-dimensional echocardiography; AROA ϭ anatomic regurgitation orifice area; CMR ϭ cardiac magnetic resonance imaging; CNR ϭ contrast-to-noise ratio; CT ϭ computed tomography; EROA ϭ effective regurgitant orifice area; LV ϭ left ventricular; MR ϭ mitral regurgitation; PISA ϭ proximal isovelocity surface area; RF ϭ regurgitant fraction; RV ϭ right ventricular; RVol ϭ regurgitant volume; SNR ϭ signal-to-noise ratio; VCA ϭ vena contracta area. *Based on hemispheric assumption. †Difference reported as mean Ϯ 2 SD. ‡Difference reported as mean Ϯ 1 SD. §Comparison data were presented for the apical window only. The better of the apical or parasternal window was used to measure the VCA. 2CH ϭ 2 chamber; 2DE ϭ 2-dimensional echocardiography; 4CH ϭ 4 chamber; ASE ϭ American Society of Echocardiography; AUC ϭ area under the curve; HE ‫؍‬ hemielliptic; HS ‫؍‬ hemispheric; ICC ϭ interclass correlation; inter ϭ interobserver variability; intra ϭ intraobserver variability; ns ϭ not significant; PLAX ϭ parasternal long axis; SD ϭ standard deviation; SEE ϭ standard error of the estimate; TEE ϭ transesophageal echocardiography; VCW ϭ vena contract width; volumetric EROA ϭ (mitral inflow stroke Table 1 . (27, 28) . To date, however, most studies (25-27,29 -31) have examined SV only at the mitral annulus or LVOT separately, with only 1 study having assessed simultaneous measurement of mitral and LVOT SV from a single 3D volume (25) . Benefits and limitations of RVol and RF quantification techniques by 3DE. There are several merits to the novel 3D color Doppler technique for the quantification of SV. In contrast to pulsed-wave Doppler sampling of velocities over a sample volume of 2 to 5 mm in diameter, this method integrates flow velocities across the entire mitral or aortic orifice to calculate SV (25, 26) . Furthermore, no assumptions are made about the LVOT or mitral annular geometry. An automated angle correction technique or a hemispheric sampling plane is used to overcome the angle dependence of color Doppler flow and a manual or automated de-aliasing algorithm to overcome color Doppler aliasing.
Although ideally suited to measure MR RVol and RF (Figs. 3D to 3F), there is only preliminary work in this area (32) . The major limitation is that it is only valid in the absence of other concomitant valvular disease or intracardiac shunting. The accuracy of the described de-aliasing algorithms is yet to be tested in the context of increased velocities across the mitral or aortic valves. With the exception of 1 study in which SV for the mitral and aortic valve for multiple heartbeats was obtained in Ͻ60 s (25) , a significant time commitment is required to quantify SV for each valve for a single cardiac cycle. Also the frame rate of 3D color Doppler acquisitions is still limited and data 
accuracy is potentially reduced at higher heart rates. Finally, the accuracy of this technique can be affected by lateral resolution, tissue priority settings, and incomplete color Doppler acquisitions at the mitral valve or LVOT. Therefore, further studies are necessary before this technique can be used clinically for MR quantification.
Validation of RVol and RF quantification techniques by CMR. Mitral RVol and RF measurements using CMR can be obtained using direct or indirect methods. The direct method utilizes PC imaging to measure RVol using SAX through-plane images at the mitral valve (Fig. 4A) (33) . The RF is then calculated as RVol divided by the LV-SV calculated from planimetry of SAX slices. The indirect methods use: 1) the difference in LV-SV by planimetry of SAX cines and aortic SV by PC imaging (Fig. 5B) (34 -36) ; 2) the difference in LV-and RV-SV by planimetry of SAX cines of the LV and RV (33,37-39); 3) the difference in mitral inflow SV across the mitral valve ( Fig. 4B ) and aortic forward SV with PC imaging (Fig. 4C ) (40); or 4) other less commonly utilized combinations of PC and volumetric analyses. The use of the difference in SVs by LV short-axis planimetry and aortic PC imaging is more practical and reproducible than the other methods (38) . Furthermore, aortic PC technique can potentially account for any aortic regurgitation present. Currently the only work that provides RF categories to grade MR severity using CMR is based on this technique (41) . However, these categories were obtained using nonquantitative echocardiographic parameters (41) as the reference standard and require further validation. To date, no studies have addressed the prognostic significance of MR quantification using CMR, test-retest variability, or its accuracy and reproducibility in a multicenter study. Benefits and limitations of RVol and RF quantification techniques by CMR. CMR is considered the reference standard for the assessment of ventricular volumes and EF, as the endocardial contours can be drawn with confidence and the volumes and EF calculated without geometric assumptions. Employing PC imaging, aortic SVs are calculated using velocities from the entire orifice (without needing to assume constant transorifice flow profile as in echocardiography with pulsed-wave Doppler). Furthermore, the RVol and RF are calculated without any hemodynamic or shape assumptions and are not affected by the direction of the MR jet (except for the direct method) or the orifice geometry. Finally, the comparable spatial resolution, but superior signal-and contrast-noise resolution, of CMR make these measurements reproducible and amenable to serial assessments.
Despite the enthusiasm for using CMR for MR quantification, there are limited data on accuracy; several of the CMR studies shown in Table 4 were not specifically performed for the validation of that technique, nor did they have an independent reference standard (33, 34, 36, 38) . Furthermore, the described techniques have some limitations. First, the indirect quantification methods can be challenging and less accurate if multiple valvular lesions or intracardiac (Fig. 4A ) is attractive as it minimizes the cumulative error that can occur from using 2 separate measurements. However, further validation of this technique is necessary before clinical use. Third, MR-RVol may be overestimated if there is inconsistency in LV endocardial contouring; namely, if the trabecular and papillary muscles are treated asymmetrically such that they are included in the blood volume at end-diastole, but excluded at end-systole, resulting in overestimation of the LV SV. Fourth, PC sequences are subject to phase offset errors due to inhomogeneity in the magnetic field (42) and can cause errors in SV computations. Various methods to overcome these errors have been suggested but can be impractical or inaccurate (43) . Fifth, the PC sequence most commonly used is a 1-dimensional, 1-directional technique and hence SVs can be underestimated if the flow is not at least nearly orthogonal to the slice position. In addition, these sequences do not account for through-plane motion of the valve plane, which can lead to underestimation of RVol. These concerns have resulted in an interest in the use of 3D, 3-directional PC imaging sequences (8) and retrospective valve tracking, although experience with these techniques is limited and imaging is time intensive. Finally, it is also unclear if the RVol and RF cut-offs suggested in the echocardiographic guidelines can be applied to the CMR measurements to classify MR severity, and our experience suggests that lower value cutoffs for CMR may be more appropriate. Further studies are therefore needed. Validation, benefits, and limitations of RVol and RF quantification by CCT. Current CCT technology does not allow flow measurements across the valves. However, RVol and RF can be measured using LV and RV contouring (37) similar to CMR. The only published study (37) showed good agreement in RVol and RF with CMR and echocardiography (Table 5 ). This technique requires a retrospectively gated acquisition with modification to contrast administration to ensure simultaneous opacification of the LV and RV. Using post-processing, software LV and RV volumes can be semiautomatically calculated or shortaxis views can be generated identical to CMR for manual planimetry. Despite the feasibility of this technique, and excellent spatial resolution, CCT is still limited by a maximum temporal resolution of 75 ms (at best), and the need for retrospectively gated acquisition resulting in higher radiation exposure. Also, this technique will be inaccurate in the presence of multivalvular disease, hence necessitating an alternate modality to first rule out concomitant valvular lesions. Therefore, CCT would be the last resort for MR severity quantification in patients with poor echocardiography windows and/or a contraindication for CMR.
PISA (EROA, RVol, RF) and Anatomic Regurgitant Orifice Area
Validation of 3DE PISA and anatomic regurgitant orifice area. The anatomic severity of MR can be assessed by 3D color Doppler using the PISA technique or by direct planimetry of the AROA. The theoretical benefit of the 3D PISA technique is the ability to measure the 3D surface of the proximal flow convergence region (PFCR) without shape assumptions (44) or to obtain the largest radius of the PFCR using 3D navigation, possibly increasing the accuracy of the EROA calculation (Fig. 5) (44,45) . Furthermore, 3DE (Table 6 ) has provided a better appreciation of the variability in the PFCR seen with different pathologies and geometric orifices and has illustrated the complexity of the PISA technique for MR quantification. Many of the studies in Table 6 have used 2DE techniques as the reference standard and hence are subject to the intrinsic limitation of these methods. The direct planimetry technique requires reconstruction of the 3DE (B-mode) to obtain an en face view of the AROA. This method was first described with reconstructed 3D TEE (46, 47) and more recently with real time 3D TEE (Table 6, Fig. 6 ). No studies to date have assessed the use of 3D TTE to measure the AROA. It is also important to remember that the AROA is theoretically larger than the EROA (19, 48) . Benefits and limitations of PISA and AROA techniques by 3DE. Although 3D data can be used to measure the "true" radius (D3), length (D1), and width (D2) of the PFCR (Fig. 5) and to apply hemispheric or other-shaped assumptions, and although the use of 3D data may improve the accuracy of the EROA calculation, it still requires assumptions about the shape of the PFCR (44, 49, 50) . Two studies have attempted to obtain a 3D surface area, one using measurement of multiple radial planes of the PFCR in an in vitro model to subsequently reconstruct the total surface area (51) , and the second using multiple linear measurements to reconstruct the 3D surface area (52) . Both methods are laborious and not practical in a busy clinical setting. There has been some recent work on automated 3D quantification of the PFCR (Fig. 5E) (32,53) ; however, further clinical validation is pending. Nonetheless, even with the 3D-surface area the issue of Doppler angle dependency (54) and the challenges of accounting for dynamic variations in EROA for RVol calculations will still exist 3D PISA Quantification
Proximal isovelocity surface area (PISA) quantification using (A to D) linear 2-dimensional (2D) measurements and (E) automated 3D surface detection. (A) Radius, (C) length (D1), and width (D2) measured from 3D TEE using multiplanar reformatting of full-volume color Doppler acquisition (D) after decreasing the aliasing velocity. Automated 3D PISA detection and quantification using 3D transthoracic echocardiography (E; green model represents the 3D PISA).
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Quantitative Assessment of Mitral Regurgitation (17, 18, 55) . Also to date there is limited experience with this technique using TEE. Finally, 3D color Doppler imaging remains limited by acquisition volume rate, which can affect identification of the largest PFCR during systole. The use of 3DE in planimetry of the AROA is attractive as unlike 2DE the 3D dataset can be reconstructed to obtain an en face view of the regurgitant orifice (Fig. 6 ). Planimetry can be used for multiple regurgitant orifices and added together, with no hemodynamic or shape assumptions necessary. However, given the contrast and spatial resolution limitations of 3DE, measurement of the AROAespecially of smaller orifices-is challenging (56) . This is Cardiac CT Study for MR Quantification by LV and RV Planimetry Tables 1 to 4 . Table 4 *Difference reported as mean Ϯ 2 SD. †Comparison with RVol and RF with LV and RV planimetry method also available but not shown here. ‡The primary intention of this study was to assess the accuracy of the Doppler technique using MRI. §Difference reported as mean Ϯ 1 SD. Data also available for comparison with direct RVol method but not shown here. ¶Calculated as average of the difference between measures divided by the mean. #A 0.5-T magnet was used, and LV and RV were contoured using 4CH stacks. CCT ϭ cardiac CT; CW ϭ continuous wave; HR ϭ heart rate; ϭ kappa; other abbreviations as in Tables 1 to 3 . ROA ϭ regurgitant orifice area; TTE ϭ transthoracic echocardiography; other abbreviations as in Tables 1 to 5. further confounded by the fact that the measurement is made in the plane with the lowest spatial resolution (lateral resolution) unless a transgastric view in TEE or a parasternal long or short axis view with TTE is used (56). Also limitations described for the VCA measurement, such as choice of systolic frame, obtaining the best en face plane, and stitching artifacts, also apply (17, 18) . Finally, although a 3D volume is used to identify the AROA, the measurement is still made using a 2D plane. A recent study illustrated that the measurement of the AROA in 3D space using 3D modeling of the mitral valve may be a better alternative to quantify MR severity (48) . Validation of AROA by CMR and CCT. Although PISA is not feasible with CMR or CCT, the AROA can be measured directly by both (Fig. 7) although not commonly used clinically. Utilizing CMR, 3 studies have assessed the use of short-axis steady-state free precession and/or fast GRE cine images for planimetry of the AROA (Figs. 7A to 7C, Table 7 ) (22,34,57); 1 of these studies reported the reproducibility of this technique (34) . Three small CCT studies, using 16 to 64 slice scanners, have examined direct planimetry of the AROA using an en face view of the regurgitant orifice from reconstructed 3D datasets (58 -60) (Figs. 7D to 7F). The latter 3 studies showed moderate to good agreement with various reference standards (Table 7) ; however, (34), is required. The choice of this orthogonal plane can introduce interobserver variability in the measurement. Unless flow-sensitive cine GRE sequences or PC imaging is used, the presence of MR may be missed by the commonly used steady-state free precession cine sequences. Through-plane motion of the mitral annulus during systole makes it challenging to image the AROA. Finally, identification of the AROA can be difficult due to partial volume effects unless the orifice is very large. With CCT, retrospective acquisition is necessary; this option is not attractive in the current era of prospectively triggered scanning with reduced radiation exposure. Even with retrospective acquisition, this measurement can be affected by limited temporal resolution. Although 2 of the 3 small studies (Table 7) show promising data, CCT should not be the primary method for AROA assessment. Finally, for both CMR and CCT, the cardiac phase in which the AROA should be measured for the various MR etiologies is unknown, as is the validity of these 2 techniques in patients with multiple MR jets.
CMR Studies Using Direct and Indirect Methods of Quantifying MR

Conclusions
The development of less invasive means of valve repair and replacement is likely to further augment the importance of MR quantitation in clinical practice. Although standard techniques for MR evaluation have been of value, their reproducibility and accuracy are limited in some patient groups. Although some of the new modalities may not be ready for adoption in all clinical imaging laboratories, this review documents their current validation. Recent technological advances in 3DE are likely to be the most suitable developments for widespread adoption, although CMR in appropriate settings may also play an important role. The role of CCT is still limited due to radiation exposure, lower temporal resolution, and the inability to assess flow. More work is needed to define the optimal strategy. CMR and CCT Studies Using Direct Planimetry To Measure Anatomic Regurgitant Orifice Area Table 7 CCT ϭ cardiac computed tomography; FISP ϭ fast imaging with steady state precession; FLASH ϭ fast low angle shot; MRI ϭ magnetic resonance imaging; PC ϭ phase contrast; SSFP ϭ steady-state free precession; VCW ϭ vena contract width; other abbreviations as in Tables 1 to 6. 
